{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:09:40Z","timestamp":1787850580304,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T00:00:00Z","timestamp":1514592000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12185-017-2397-8","type":"journal-article","created":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T13:35:54Z","timestamp":1514640954000},"page":"203-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-7931","authenticated-orcid":false,"given":"Kazuya","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,30]]},"reference":[{"issue":"23","key":"2397_CR1","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol. 2011;29(23):3179\u201384.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2397_CR2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-01-071068","volume":"110","author":"F Passamonti","year":"2007","unstructured":"Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. Blood. 2007;110(2):485\u20139.","journal-title":"Blood"},{"issue":"10","key":"2397_CR3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ajh.21504","volume":"84","author":"L Melillo","year":"2009","unstructured":"Melillo L, Tieghi A, Candoni A, Radaelli F, Ciancia R, Specchia G, et al. Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. Am J Hematol. 2009;84(10):636\u201340.","journal-title":"Am J Hematol"},{"issue":"5","key":"2397_CR4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00062752-199704050-00007","volume":"4","author":"SM Bates","year":"1997","unstructured":"Bates SM, Ginsberg JS. Thrombosis in pregnancy. Curr Opin Hematol. 1997;4(5):335\u201343.","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2397_CR5","first-page":"143","volume":"36","author":"Y Asano","year":"1987","unstructured":"Asano Y, Okaniwa A. In utero morphological effects of hydroxyurea on the fetal development in Sprague\u2013Dawley rats. Jikken Dobutsu. 1987;36(2):143\u20139.","journal-title":"Jikken Dobutsu"},{"issue":"4","key":"2397_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.2830410405","volume":"41","author":"EY Chow","year":"1992","unstructured":"Chow EY, Haley LP, Vickars LM. Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome. Am J Hematol. 1992;41(4):249\u201351.","journal-title":"Am J Hematol"},{"issue":"1","key":"2397_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V","volume":"53","author":"P Pagliaro","year":"1996","unstructured":"Pagliaro P, Arrigoni L, Muggiasca ML, Poggio M, Russo U, Rossi E. Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. Am J Hematol. 1996;53(1):6\u201310.","journal-title":"Am J Hematol"},{"issue":"5","key":"2397_CR8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/leu.2011.306","volume":"26","author":"G Finazzi","year":"2012","unstructured":"Finazzi G. How to manage essential thrombocythemia. Leukemia. 2012;26(5):875\u201382.","journal-title":"Leukemia"},{"issue":"17","key":"2397_CR9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","volume":"332","author":"S Cortelazzo","year":"1995","unstructured":"Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995;332(17):1132\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"2397_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000253030","volume":"122","author":"MA Sobas","year":"2009","unstructured":"Sobas MA, Perez Encinas MM, Rabunal Martinez MJ, Quinteiro Garcia C, Bello Lopez JL. Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review. Acta Haematol. 2009;122(4):221\u20132.","journal-title":"Acta Haematol"},{"issue":"3","key":"2397_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","volume":"149","author":"CN Harrison","year":"2010","unstructured":"Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010;149(3):352\u201375.","journal-title":"Br J Haematol"},{"issue":"6","key":"2397_CR12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0609.2004.00324.x","volume":"73","author":"R Niittyvuopio","year":"2004","unstructured":"Niittyvuopio R, Juvonen E, Kaaja R, Oksanen K, Hallman H, Timonen T, et al. Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. Eur J Haematol. 2004;73(6):431\u20136.","journal-title":"Eur J Haematol"},{"issue":"6","key":"2397_CR13","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ajog.2004.05.001","volume":"191","author":"P Martinelli","year":"2004","unstructured":"Martinelli P, Martinelli V, Agangi A, Maruotti GM, Paladini D, Ciancia R, et al. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review. Am J Obstet Gynecol. 2004;191(6):2016\u201320.","journal-title":"Am J Obstet Gynecol"},{"issue":"20","key":"2397_CR14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2169\/internalmedicine.45.1879","volume":"45","author":"T Iwashita","year":"2006","unstructured":"Iwashita T, Fujitani M, Yamamoto Y, Katsurada T, Yoshida Y. Interferon-alfa treatment of essential thrombocythemia during pregnancy. Intern Med. 2006;45(20):1161\u20134.","journal-title":"Intern Med"},{"issue":"4","key":"2397_CR15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/09537104.2011.611919","volume":"23","author":"N Singh","year":"2012","unstructured":"Singh N, Kumar S, Roy KK, Sharma V, Jalak A. Successful maternal and fetal outcome in a rare case of essential thrombocythemia with pregnancy using interferon alpha. Platelets. 2012;23(4):319\u201321.","journal-title":"Platelets"},{"issue":"3","key":"2397_CR16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2141.1994.tb05092.x","volume":"88","author":"JM Williams","year":"1994","unstructured":"Williams JM, Schlesinger PE, Gray AG. Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon. Br J Haematol. 1994;88(3):647\u20138.","journal-title":"Br J Haematol"},{"issue":"2","key":"2397_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2141.1996.d01-1476.x","volume":"92","author":"O Shpilberg","year":"1996","unstructured":"Shpilberg O, Shimon I, Sofer O, Dolitski M, Ben-Bassat I. Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia. Br J Haematol. 1996;92(2):491\u20133.","journal-title":"Br J Haematol"},{"issue":"3","key":"2397_CR18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood.V83.3.874.874","volume":"83","author":"N Vianelli","year":"1994","unstructured":"Vianelli N, Gugliotta L, Tura S, Bovicelli L, Rizzo N, Gabrielli A. Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia. Blood. 1994;83(3):874\u20135.","journal-title":"Blood"},{"key":"2397_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<331::AID-AJH21>3.0.CO;2-F","volume":"52","author":"JL Diez-Martin","year":"1996","unstructured":"Diez-Martin JL, Banas MH, Fernandez MN. Childbearing age patients with essential thrombocythemia: should they be placed on interferon? Am J Hematol. 1996;52:331\u20132.","journal-title":"Am J Hematol"},{"issue":"2","key":"2397_CR20","first-page":"495","volume":"93","author":"M Pulik","year":"1996","unstructured":"Pulik M, Lionnet F, Genet P, Petitdidier C, Jary L. Platelet counts during pregnancy in essential thrombocythaemia treated with recombinant alpha-interferon. Br J Haematol. 1996;93(2):495.","journal-title":"Br J Haematol"},{"issue":"3","key":"2397_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.2830460312","volume":"46","author":"M Perez-Encinas","year":"1994","unstructured":"Perez-Encinas M, Bello JL, Perez-Crespo S, De Miguel R, Tome S. Familial myeloproliferative syndrome. Am J Hematol. 1994;46(3):225\u20139.","journal-title":"Am J Hematol"},{"key":"2397_CR22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00277-017-2946-5","volume":"96","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Katsurada T, Nakabou Y, Kawabata H. Efficacy of interferon-alpha in essential thrombocythemia during pregnancy. Ann Hematol. 2017;96:877\u20138.","journal-title":"Ann Hematol"},{"issue":"3","key":"2397_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2005.05400.x","volume":"129","author":"C Harrison","year":"2005","unstructured":"Harrison C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol. 2005;129(3):293\u2013306.","journal-title":"Br J Haematol"},{"issue":"3","key":"2397_CR24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000057634","volume":"107","author":"B Vantroyen","year":"2002","unstructured":"Vantroyen B, Vanstraelen D. Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. Acta Haematol. 2002;107(3):158\u201369.","journal-title":"Acta Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2397-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2397-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2397-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T02:32:53Z","timestamp":1603593173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2397-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,30]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2397-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,30]]}}}